Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Ascentage Pharma Group International - Unsponsored ADR (AAPG) Stock-Based Compensation data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$337.99M |
|
$110.76M |
|
$139.63M |
|
$477.62M |
|
$277.59M |
|
$91.30M |
|
$116.63M |
|
$394.23M |
|
$83.39M |
|
$74.22M |
|
$83.39M |
|
93.39M |
|
| Cash Flow Statement Financials | |
$-85.66M |
|
$137.13M |
|
$10.86M |
|
$176.24M |
|
$230.97M |
|
$54.73M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|